Changeflow GovPing Pharma & Drug Safety AbbVie ABBV-295 phase 1 trial, Japanese adults,...
Routine Notice Added

AbbVie ABBV-295 phase 1 trial, Japanese adults, obesity

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected April 7th, 2026
Email

Summary

AbbVie ABBV-295 phase 1 trial, Japanese adults, obesity

View original document View source feed page

Source document (simplified)

Show glossary

Related changes

Favicon for clinicaltrials.gov Acupuncture and Chinese herbal fumigation for chronic neck pain, Malaysia
Routine Apr 07, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov Clinical Trial Study NCT07515573
Routine Apr 07, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov Clinical Trial - HPV Oropharyngeal Cancer, Medical University of South Carolina
Routine Apr 07, 2026 • ClinicalTrials.gov • Pharma & Drug Safety

Get daily alerts for ClinicalTrials.gov

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Favicon for clinicaltrials.gov
ClinicalTrials.gov clinicaltrials.gov/ct2/results/rss.xml
Pharma & Drug Safety
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
GP
Instrument
Notice

Browse Categories

Agriculture & Food Safety 63 AI Regulation 3 Banking & Finance 287 Consumer Protection 44 Courts & Legal 361 Data Privacy & Cybersecurity 74 Defense & National Security 52 Education 20 Energy 101 Environment 85 Environmental Permits 1 Environmental Regulation 13 Government & Legislation 278 Healthcare 136 Housing 16 Immigration 9 Insurance 58 Labor & Employment 113 Legislative 1 Pharma & Drug Safety 104 Public Health 3 Securities & Markets 104 Securities Regulation 14 Tax 66 Telecom & Technology 47 Trade & Sanctions 124 Transportation 57

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.